<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-44686</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0085831</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Anatomy and physiology</subject><subj-group><subject>Cardiovascular system</subject><subj-group><subject>Circulatory physiology</subject></subj-group></subj-group></subj-group><subj-group><subject>Cardiovascular</subject><subj-group><subject>Aortic diseases</subject></subj-group></subj-group><subj-group><subject>Clinical research design</subject><subj-group><subject>Case-control studies</subject><subject>Epidemiology</subject><subject>Meta-analyses</subject><subject>Retrospective studies</subject><subject>Systematic reviews</subject></subj-group></subj-group><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Test evaluation</subject></subj-group></subj-group><subj-group><subject>Epidemiology</subject><subj-group><subject>Cardiovascular disease epidemiology</subject><subject>Clinical epidemiology</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Homocysteine Level and Risk of Abdominal Aortic Aneurysm: A Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">Homocysteine Level and Risk of AAA</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cao</surname><given-names>Hui</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hu</surname><given-names>Xinhua</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>Qiang</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Junpeng</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Shao</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>Bing</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Xin</surname><given-names>Shijie</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
</contrib-group>
<aff id="aff1"><addr-line>Department of Vascular and Thyriod Surgery, the First Affiliated Hospital of China Medical University, Shenyang, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Sen</surname><given-names>Utpal</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Louisville, United States of America</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">xhhu@mail.cmu.edu.cn</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: HC XHH. Performed the experiments: HC JL. Analyzed the data: XHH QZ. Contributed reagents/materials/analysis tools: JPW YS BL SJX. Wrote the paper: HC XHH QZ.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>21</day><month>1</month><year>2014</year></pub-date>
<volume>9</volume>
<issue>1</issue>
<elocation-id>e85831</elocation-id>
<history>
<date date-type="received"><day>31</day><month>10</month><year>2013</year></date>
<date date-type="accepted"><day>27</day><month>11</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Cao et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract><sec>
<title>Objectives</title>
<p>Previous studies have reported inconsistent findings regarding the association between elevated plasma homocysteine (Hcy) levels and abdominal aortic aneurysm (AAA). We investigated this association between Hcy levels in patients with AAA and unaffected controls by conducting a meta-analysis and systematic review.</p>
</sec><sec>
<title>Methods</title>
<p>We conducted a systematic literature search (up to August 2013) of the PubMed database and Embase. We selected observational studies that evaluated Hcy levels in subjects with AAA compared to unaffected controls. Criteria for inclusion were the assessment of baseline Hcy and risk of AAA as an outcome. The results were presented as odd ratio (OR) and corresponding 95% confidence intervals (CI) comparing AAA patients to the control subjects.</p>
</sec><sec>
<title>Results</title>
<p>7 studies with 6,445 participants were identified and analyzed. Overall, elevated plasma Hcy was associated with an increased risk of AAA (3.29; 95% CI 1.66–6.51). The pooled adjusted OR from a random effect model of only men participants in the AAA compared with the control group was 2.36 (95% CI 0.63–8.82).</p>
</sec><sec>
<title>Conclusion</title>
<p>This meta-analysis and systematic review suggested that Hcy significantly increased the risk of AAA.</p>
</sec></abstract>
<funding-group><funding-statement>This work was supported by National Nature Science Foundation of China (81070254, 30872527 and 30672048). URL: <ext-link ext-link-type="uri" xlink:href="http://www.nsfc.gov.cn/Portal0/default152.htm" xlink:type="simple">http://www.nsfc.gov.cn/Portal0/default152.htm</ext-link>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="7"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Abdominal aortic aneurysm (AAA) is an abnormal dilatation of the abdominal aorta, exceeding the normal aortic diameter by at least 50%. Aortic aneurysms do not tend to cause any symptoms and are often diagnosed incidentally on physical examination or imaging investigations for other unrelated conditions <xref ref-type="bibr" rid="pone.0085831-Cosford1">[1]</xref>, <xref ref-type="bibr" rid="pone.0085831-Maegdefessel1">[2]</xref>. Screening demonstrates that disease prevalence ranges from 1.3% (45–54 years of age) to 12.5% in men (75–84 years of age), and in women from 0% in the youngest to 5.2% in the oldest age groups <xref ref-type="bibr" rid="pone.0085831-Go1">[3]</xref>. Currently there are no recognized treatments to diminish aneurysm progression at an early stage and a pharmacological treatment that targeted the processes underlying aortic dilatation <xref ref-type="bibr" rid="pone.0085831-Harrison1">[4]</xref>.</p>
<p>Homocysteine (Hcy) is a branch-point intermediate of methionine metabolism, which can be further metabolised via two alternative pathways: degraded irreversibly through the transsulfuration pathway or remethylated to methionine by the remethylation pathway <xref ref-type="bibr" rid="pone.0085831-Wong1">[5]</xref>, <xref ref-type="bibr" rid="pone.0085831-Giusti1">[6]</xref>. Vitamin B and folate are major determinants of Hcy metabolism and supplementation with vitamin B and folic acid has been shown to be effective in normalizing Hcy levels <xref ref-type="bibr" rid="pone.0085831-Selhub1">[7]</xref>–<xref ref-type="bibr" rid="pone.0085831-Berti1">[10]</xref>. Elevated total plasma level of Hcy has been shown to correlate strongly with coronary artery disease <xref ref-type="bibr" rid="pone.0085831-Humphrey1">[11]</xref>, <xref ref-type="bibr" rid="pone.0085831-MartiCarvajal1">[12]</xref>, stroke <xref ref-type="bibr" rid="pone.0085831-Wald1">[13]</xref>, <xref ref-type="bibr" rid="pone.0085831-Casas1">[14]</xref>, fracture <xref ref-type="bibr" rid="pone.0085831-vanWijngaarden1">[9]</xref>, <xref ref-type="bibr" rid="pone.0085831-Yang1">[15]</xref>, venous thrombosis <xref ref-type="bibr" rid="pone.0085831-Wald1">[13]</xref>, and may increase the risk of retinal artery <xref ref-type="bibr" rid="pone.0085831-Cahill1">[16]</xref> and vein occlusion <xref ref-type="bibr" rid="pone.0085831-McGimpsey1">[17]</xref> and nonarteritic anterior ischemic optic neuropathy <xref ref-type="bibr" rid="pone.0085831-Pianka1">[18]</xref>. Several studies reported that the elevated Hcy concentrations were identified as a potentially modifiable risk factor for abdominal aortic aneurysms <xref ref-type="bibr" rid="pone.0085831-Wong1">[5]</xref>, <xref ref-type="bibr" rid="pone.0085831-Giusti1">[6]</xref>, <xref ref-type="bibr" rid="pone.0085831-Peeters1">[19]</xref>-<xref ref-type="bibr" rid="pone.0085831-Brunelli1">[23]</xref>. Based on the previously published clinical evidence, a clinical review demonstrated there is evidence for an association between Hcy and AAA <xref ref-type="bibr" rid="pone.0085831-Moroz1">[24]</xref>. However, it is not strong enough to conclude that it plays a causal role in the pathogenesis of AAA. In the current study, we performed a meta-analysis to assess the relationship between Hcy and AAA in the literature. The aim of the current meta-analysis and systematic review was to quantitatively evaluate findings from observational studies on the plasma level of Hcy and the incidence of AAA.</p>
</sec><sec id="s2" sec-type="methods">
<title>Methods</title>
<p>This study was conducted in accordance with the ‘preferred reporting items for systematic reviews and meta-analyses'(PRISMA) guidelines. No protocol exists for this meta-analysis.</p>
<sec id="s2a">
<title>Search strategy</title>
<p>We conducted a PubMed database and Embase search (up to August 2013) for studies assessing the association between AAA and Hcy. Papers could be published in English and Chinese. Potentially relevant studies were identified by various combinations of the following search terms: abdominal aortic aneurysm, hyperhomocysteinemia, homocysteine, folate, folic acid, vitamin B<sub>6</sub>, and pyridoxine. In addition, we also manually searched the reference lists to detect additional eligible studies.</p>
</sec><sec id="s2b">
<title>Study selection</title>
<p>Studies satisfying the following criteria were included in the observational meta-analysis: 1) providing raw data dealing with AAA and Hcy level and the risk of AAA; 2) AAA was defined as computed tomography (CT) and ultrasonographically proven infrarenal aortic diameter ≥30 mm); 3) Hcy level was measured at baseline using a technique standardized in each study; 4) providing adjusted odd ratio (OR) and the 95% confidence interval (CI) comparing the Hcy level of AAA to the control group. Exclusion criteria were: reviews, letters, case-reports, animal studies or the participants in a highly selected disease.</p>
</sec><sec id="s2c">
<title>Data extraction and quality assessment</title>
<p>Two reviewers (Xinhua Hu and Qiang Zhang) independently extracted the data according to predefined criteria using a “AAA associated with Hcy extraction form” developed specifically for the review. The OR and 95% CI were extracted. When both crude and adjusted OR were provided, we used the most fully adjusted OR for all the included studies. We also extracted the following items from each individual study: author; year of publication; the country of study; the sample size; gender; and the mean age or age range of participants; Hcy level; case and control number. Where discrepancies were identified, reviewers resolved these by discussion.</p>
<p>Quality assessment that was performed with consideration of the following aspects followed the Newcastle-Ottawa Scale <xref ref-type="bibr" rid="pone.0085831-Wells1">[25]</xref>: 1) Selection (4 scores): is the case definition, representativeness of the cases, selection of controls, and definition of controls. 2) Comparability (2 scores): select the most important factor, the criteria could be modified to indicate specific control for as second important factor. 3) Exposure (3 scores): ascertainment of exposure, same method of ascertainment for cases and controls, and non-response rate.</p>
</sec><sec id="s2d">
<title>Statistical analysis</title>
<p>The OR was used as the common measure across studies. Data analysis used multivariate-adjusted OR and 95% CI. If the publications reported separately OR for smoker, we chose the separate OR estimates for the different items comparing AAA to the control from individual study. Before pooling the data, adjusted OR from each study was converted to their logOR to stabilize the variances and to normalize the distributions. The standard errors (SEs) for logOR were calculated from reported 95% CI. Homogeneity of OR across studies was assessed by using the Cochrane Q statistic (p&lt;0.10 was considered indicative of statistically significant heterogeneity) and I<sup>2</sup> statistic (values of less than 40% as “heterogeneity might not be important ” and of more than 75% as “considerable heterogeneity”, based on the suggestion of the Cochrane Handbook for Systematic Review of Interventions) <xref ref-type="bibr" rid="pone.0085831-Higgins1">[26]</xref>. The pooled OR was computed using either fixed-effects models or, in the presence of heterogeneity, random-effects models <xref ref-type="bibr" rid="pone.0085831-DerSimonian1">[27]</xref>.</p>
<p>We constructed a funnel plot with logOR and their SEs of logOR using AAA by visual inspection to assess the potential publication bias. Potential publication bias was also assessed by both Begg' rank correlation test <xref ref-type="bibr" rid="pone.0085831-Begg1">[28]</xref> and Egger linear regression test at the p&lt;0.10 level of significance <xref ref-type="bibr" rid="pone.0085831-Egger1">[29]</xref>. Finally, sensitivity analysis was used to investigate the influence of a single study on the overall risk estimate, and was carried out by sequentially omitting one study at each turn with the metaninf algorithm in STATA. All analysis was performed using STATA version 12.0 statistical software (Stata Corp LP, College Station). A p value &lt;0.05 was considered as statistically significant.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Literature search</title>
<p>After the application of search strategy, a total of 85 potentially relevant citations were identified in our initial literature search. After reviewing the full-texts, only 7 studies met the inclusion criteria <xref ref-type="bibr" rid="pone.0085831-Wong1">[5]</xref>, <xref ref-type="bibr" rid="pone.0085831-Giusti1">[6]</xref>, <xref ref-type="bibr" rid="pone.0085831-Peeters1">[19]</xref>–<xref ref-type="bibr" rid="pone.0085831-Brunelli1">[23]</xref>. Analysis was carried out on 1410 patients with an AAA (infrarenal aortic diameter ≥30 mm) and 5035 age and sex matched controls. A flow chart showing the study selection is presented in <xref ref-type="fig" rid="pone-0085831-g001">Fig 1</xref>. No additional studies were identified through our hand search of references from published studies.</p>
<fig id="pone-0085831-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0085831.g001</object-id><label>Figure 1</label><caption>
<title>Flow chart of study selection process for meta-analysis.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0085831.g001" position="float" xlink:type="simple"/></fig></sec><sec id="s3b">
<title>Baseline characteristics and quality assessment</title>
<p>Characteristics of the included studies were listed in <xref ref-type="table" rid="pone-0085831-t001">Table 1</xref>. The qualities of the included studies were listed in <xref ref-type="table" rid="pone-0085831-t002">Table 2</xref>.</p>
<table-wrap id="pone-0085831-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0085831.t001</object-id><label>Table 1</label><caption>
<title>Summary of clinical studies included in meta-analysis.</title>
</caption><alternatives><graphic id="pone-0085831-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0085831.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Study/year</td>
<td align="left" rowspan="1" colspan="1">Country</td>
<td align="left" rowspan="1" colspan="1">Design</td>
<td align="left" rowspan="1" colspan="1">Subjects</td>
<td align="left" rowspan="1" colspan="1">Age/range Mean(SD)</td>
<td align="left" rowspan="1" colspan="1">Male</td>
<td colspan="2" align="left" rowspan="1">Hcy levels (Mean±SD), µmol/L</td>
<td align="left" rowspan="1" colspan="1">OR (95% CI)</td>
<td align="left" rowspan="1" colspan="1">Adjustment for covariates</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">cases/controls</td>
<td align="left" rowspan="1" colspan="1">cases/controls</td>
<td align="left" rowspan="1" colspan="1">cases/controls</td>
<td align="left" rowspan="1" colspan="1">AAA patients</td>
<td align="left" rowspan="1" colspan="1">controls</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Wong YYE (2013)</td>
<td align="left" rowspan="1" colspan="1">Australia</td>
<td align="left" rowspan="1" colspan="1">case-control study</td>
<td align="left" rowspan="1" colspan="1">318/3930</td>
<td align="left" rowspan="1" colspan="1">77.7±4.1/76.5±3.6</td>
<td align="left" rowspan="1" colspan="1">318/3930</td>
<td align="left" rowspan="1" colspan="1">15.1±6.1</td>
<td align="left" rowspan="1" colspan="1">13.2±5.1</td>
<td align="left" rowspan="1" colspan="1">1.45(1.10–1.91)</td>
<td align="left" rowspan="1" colspan="1">Age, sex,smoking, hypertension, BMI, aortic diameter, dyslipidemia, diabetes, Cardiovascular disease, hsCRP</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Giusti B (2008)</td>
<td align="left" rowspan="1" colspan="1">Italy</td>
<td align="left" rowspan="1" colspan="1">case-control study</td>
<td align="left" rowspan="1" colspan="1">423/423</td>
<td align="left" rowspan="1" colspan="1">73.5(40–94)/72(41–94)</td>
<td align="left" rowspan="1" colspan="1">376/366</td>
<td align="left" rowspan="1" colspan="1">15.3(6.7–144.3)</td>
<td align="left" rowspan="1" colspan="1">14.1(6.1–94.9)</td>
<td align="left" rowspan="1" colspan="1">1.1(1.01–1.20)</td>
<td align="left" rowspan="1" colspan="1">Age, sex,smoking, hypertension, dyslipidemia, diabetes mellitus, and COPD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Peeters AC (2007)</td>
<td align="left" rowspan="1" colspan="1">Netherlands</td>
<td align="left" rowspan="1" colspan="1">case-control study</td>
<td align="left" rowspan="1" colspan="1">88/88</td>
<td align="left" rowspan="1" colspan="1">69(45–85)/67(44–83)</td>
<td align="left" rowspan="1" colspan="1">81/81</td>
<td align="left" rowspan="1" colspan="1">quartil 9.33,11.8,15.1</td>
<td align="left" rowspan="1" colspan="1">N</td>
<td align="left" rowspan="1" colspan="1">0.78(01.7–3.62)</td>
<td align="left" rowspan="1" colspan="1">Age, sex,smoking, hypertension, dyslipidemia, concentration of creatinine, vitamin B<sub>6</sub>, B<sub>12</sub>, and folate</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sofi F(2005)</td>
<td align="left" rowspan="1" colspan="1">Italy</td>
<td align="left" rowspan="1" colspan="1">case-control study</td>
<td align="left" rowspan="1" colspan="1">438/438</td>
<td align="left" rowspan="1" colspan="1">74(40–94)/73.4(48–84)</td>
<td align="left" rowspan="1" colspan="1">397/391</td>
<td align="left" rowspan="1" colspan="1">16.2(7.3–93.6)</td>
<td align="left" rowspan="1" colspan="1">11(6–24.6)</td>
<td align="left" rowspan="1" colspan="1">7.8(4.60–13.20)</td>
<td align="left" rowspan="1" colspan="1">Age, sex,smoking, hypertension, aortic diameter, dyslipidemia</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Warsi AA (2004)</td>
<td align="left" rowspan="1" colspan="1">UK</td>
<td align="left" rowspan="1" colspan="1">case-control study</td>
<td align="left" rowspan="1" colspan="1">38/36</td>
<td align="left" rowspan="1" colspan="1">70(53–79)/66(48–79)</td>
<td align="left" rowspan="1" colspan="1">35/21</td>
<td align="left" rowspan="1" colspan="1">19.4</td>
<td align="left" rowspan="1" colspan="1">10.9</td>
<td align="left" rowspan="1" colspan="1">9.75(2.17–43.77)</td>
<td align="left" rowspan="1" colspan="1">Age, sex,smoking, hypertension, aortic diameter, dyslipidemia, diabetes, cardiac disease, stroke</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Spark JI (2003)</td>
<td align="left" rowspan="1" colspan="1">Australia</td>
<td align="left" rowspan="1" colspan="1">case-control study</td>
<td align="left" rowspan="1" colspan="1">47/60</td>
<td align="left" rowspan="1" colspan="1">N</td>
<td align="left" rowspan="1" colspan="1">N</td>
<td align="left" rowspan="1" colspan="1">17.9(14.8–20.8)</td>
<td align="left" rowspan="1" colspan="1">8.5(7.0–11.8)</td>
<td align="left" rowspan="1" colspan="1">15.9(4.96–51.00)</td>
<td align="left" rowspan="1" colspan="1">Age, sex,smoking, hypertension, aortic diameter, dyslipidemia,diabetes, cholesterol</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Brunelli T (2000)</td>
<td align="left" rowspan="1" colspan="1">Italy</td>
<td align="left" rowspan="1" colspan="1">case-control study</td>
<td align="left" rowspan="1" colspan="1">58/60</td>
<td align="left" rowspan="1" colspan="1">69.3±6.7/67.6±7.0</td>
<td align="left" rowspan="1" colspan="1">58/60</td>
<td align="left" rowspan="1" colspan="1">15.7±6.5</td>
<td align="left" rowspan="1" colspan="1">9.6±3.9</td>
<td align="left" rowspan="1" colspan="1">6(1.23–29.6)</td>
<td align="left" rowspan="1" colspan="1">Age, smoking, hypertension, aortic diameter, diabetes mellitus, Hypercholesterolemia, Hypertriglyceridemia</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>Abbreviations: Body mass index, BMI; odd ratio, OR; not provide, N; chronic obstructive pulmonary disease, COPD; high-sensitivity C-reactive protein, hsCRP.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0085831-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0085831.t002</object-id><label>Table 2</label><caption>
<title>The Newcastle-Ottawa Quality Assessment Scale for case–control studies.</title>
</caption><alternatives><graphic id="pone-0085831-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0085831.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Study</td>
<td align="left" rowspan="1" colspan="1">Selection</td>
<td align="left" rowspan="1" colspan="1">Comparability</td>
<td align="left" rowspan="1" colspan="1">Outcome</td>
<td align="left" rowspan="1" colspan="1">Summary</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Wong YYE (2013)</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Giusti B (2008)</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Peeters AC (2007)</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sofi F (2005)</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Warsi AA (2004)</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Spark JI (2003)</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Brunelli T (2000)</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">8</td>
</tr>
</tbody>
</table>
</alternatives></table-wrap></sec><sec id="s3c">
<title>Association of plasma Hcy with all AAA</title>
<p>7 studies <xref ref-type="bibr" rid="pone.0085831-Wong1">[5]</xref>, <xref ref-type="bibr" rid="pone.0085831-Giusti1">[6]</xref>, <xref ref-type="bibr" rid="pone.0085831-Peeters1">[19]</xref>–<xref ref-type="bibr" rid="pone.0085831-Brunelli1">[23]</xref> reported AAA and Hcy. The total number of participants included in this meta-analysis was 6445 with 1410 total AAA patients. As shown in <xref ref-type="fig" rid="pone-0085831-g002">Fig 2</xref>, the pooled adjusted OR from a random effect model for all studies combined for the Hcy levels that was associated from a random effect model of participants with AAA was 3.29 (95% CI 1.66–6.51), with evidence of significant heterogeneity (I<sup>2</sup> = 92.9%; p = 0.000). The pooled OR from a fixed-effect model was 1.21 (95% CI, 1.11–1.31).</p>
<fig id="pone-0085831-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0085831.g002</object-id><label>Figure 2</label><caption>
<title>OR and 95% CI from the included studies of plasma Hcy level and AAA.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0085831.g002" position="float" xlink:type="simple"/></fig>
<p>Of the 7 included studies 3 actually had more than 100 subjects within each cohort <xref ref-type="bibr" rid="pone.0085831-Wong1">[5]</xref>, <xref ref-type="bibr" rid="pone.0085831-Giusti1">[6]</xref>, <xref ref-type="bibr" rid="pone.0085831-Sofi1">[20]</xref>, and the pooled adjusted OR from a random effect model for the 3 studies combined for the Hcy levels that was associated from a random effect model of participants with AAA was 2.20 (95% CI 1.01–4.80), with evidence of significant heterogeneity (I<sup>2</sup> = 96.3%; p = 0.000) (<xref ref-type="fig" rid="pone-0085831-g003">Fig 3</xref>). 4 studies had less than 100 subjects <xref ref-type="bibr" rid="pone.0085831-Peeters1">[19]</xref>, <xref ref-type="bibr" rid="pone.0085831-Warsi1">[21]</xref>–<xref ref-type="bibr" rid="pone.0085831-Brunelli1">[23]</xref>, and the pooled adjusted OR from a random effect model for the 4 studies combined for the Hcy levels that was associated from a random effect model of participants with AAA was 5.43 (95% CI 1.47–20.01), with evidence of significant heterogeneity (I<sup>2</sup> = 69.8%; p = 0.019) (<xref ref-type="fig" rid="pone-0085831-g004">Fig 4</xref>).</p>
<fig id="pone-0085831-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0085831.g003</object-id><label>Figure 3</label><caption>
<title>OR and 95% CI from the studies with &gt;100 patients of plasma Hcy level and AAA.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0085831.g003" position="float" xlink:type="simple"/></fig><fig id="pone-0085831-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0085831.g004</object-id><label>Figure 4</label><caption>
<title>OR and 95% CI from the studies with &lt;100 patients of plasma Hcy level and AAA.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0085831.g004" position="float" xlink:type="simple"/></fig>
<p>As shown in <xref ref-type="fig" rid="pone-0085831-g005">Fig 5</xref>, the pooled adjusted OR in two studies <xref ref-type="bibr" rid="pone.0085831-Wong1">[5]</xref>, <xref ref-type="bibr" rid="pone.0085831-Brunelli1">[23]</xref> from a random effect model of participants with AAA in the high Hcy group compared with the normal Hcy concentrations group only men was 2.36 (95% CI 0.63–8.82), with evidence of significant heterogeneity (I<sup>2</sup> = 66.4%; p = 0.085).</p>
<fig id="pone-0085831-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0085831.g005</object-id><label>Figure 5</label><caption>
<title>OR and 95% CI from the included studies of plasma Hcy level and AAA by men.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0085831.g005" position="float" xlink:type="simple"/></fig></sec><sec id="s3d">
<title>Sensitive analysis on AAA</title>
<p>As shown in <xref ref-type="fig" rid="pone-0085831-g006">Fig 6</xref>, in the metainf analysis, there was little change in the quantitative summary measure of OR or 95% CI.</p>
<fig id="pone-0085831-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0085831.g006</object-id><label>Figure 6</label><caption>
<title>OR and 95% CI by omitting each study from the included studies of plasma Hcy and AAA.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0085831.g006" position="float" xlink:type="simple"/></fig></sec><sec id="s3e">
<title>Assessment of publication bias</title>
<p>Evidence of publication bias for studies reporting adjusted OR of AAA was noted in asymmetrical funnel plot on visual inspection, and Egger' s linear regression test (p = 0.049), but not in the Begg's rank correlation test (p = 1.000). There was no evidence of publication bias for studies reporting adjusted OR of abdominal aortic diameter, this was further confirmed by Begg's rank correlation test (p = 0.806) and Egger's linear regression test (p = 0.136).</p>
</sec></sec><sec id="s4">
<title>Discussion</title>
<p>The findings of the current meta-analysis provided evidence that Hcy was a predictor of increased AAA risk. Subjects with elevated Hcy increased risk of AAA (OR 3.29; 95% CI 1.66–6.51).</p>
<p>The major environmental exposures associated with AAA development include sex, advancing age, cigarette smoking, dyslipidaemia, and hypertension <xref ref-type="bibr" rid="pone.0085831-Forsdahl1">[30]</xref>. In the current meta-analysis, male was not associated with a markedly increase AAA risk (OR 2.36; 95% CI 0.63–8.28). However, due to the limited included study number and low proportion (376 of 1410) of AAA, the apparent lack of association with AAA and gender might be not convincing.</p>
<p>Pathological characterization of AAA includes intimal atheroma, infiltration of inflammatory cells, such as macrophages, T lymphocytes, neutrophils and dendritic cells and activated platelets into the aortic wall. These early events are followed by extracellular matrix (ECM) destruction and remodelling, vascular smooth muscle cell (VSMC) depletion and dysfunction <xref ref-type="bibr" rid="pone.0085831-Krishna1">[31]</xref>. Experiments had demonstrated that Hcy stimulates chemokine and cytokine secretion from cultured human monocytes and has been implicated in suppressing regulatory T-cell function <xref ref-type="bibr" rid="pone.0085831-Feng1">[32]</xref>. A recent interesting study by Liu Z et al., within an angiotensin II induced AAA mouse model suggests that hyper-Hcy exaggerates adventitial inflammation, promoting AAA <xref ref-type="bibr" rid="pone.0085831-Liu1">[33]</xref>. Hcy induces the synthesis of serine elastase in arterial smooth muscle cells, causing elastolysis by degradation of the extracellular matrix and release of reactive oxygen species, which are implicated in AAA pathogenesis <xref ref-type="bibr" rid="pone.0085831-JourdheuilRahmani1">[34]</xref>, <xref ref-type="bibr" rid="pone.0085831-Ke1">[35]</xref>. Whether Hcy plays a role in aneurysm formation and/or in aneurysm expansion or Hcy is simply a marker of the condition need to be investigated.</p>
<p>Plasma Hcy levels are also influenced by several factors such as genetic factors <xref ref-type="bibr" rid="pone.0085831-denHeijer1">[36]</xref>, <xref ref-type="bibr" rid="pone.0085831-Jee1">[37]</xref>, plasma folate and vitamin B<sub>12</sub> concentrations. Selhub and colleagues have suggested that inadequate plasma concentrations of one or more B vitamins are contributing factors in approximately two thirds of all cases of hyperhomocysteinaemia and that vitamin supplementation can normalise high homocysteine concentrations <xref ref-type="bibr" rid="pone.0085831-Selhub1">[7]</xref>. As lack of well-designed RCTs, we were unable to perform a meta-analysis of the clinical effects of Hcy-lowering therapy among the limited studies because of the in consistent outcomes. Hcy-lowering therapy by folic acid, vitamins B<sub>6</sub> and B<sub>12</sub> supplement will help to reduce rates of AAA or not, the answer maybe urgent in the development of interventions to prevent AAA. More well-design RCTs are needed to test the effects of Hcy-lowering therapy on the AAA incident.</p>
<p>Although we only included the case-control studies in the analysis, there are still several potential limitations. First, because of the cross-sectional design, the studies are unable to determine if the altered parameters are causally related to the presence of AAA. Second, we only included the study in English and Chinese, and some relevant studies might be not included in the review. There was a low risk of publication bias in studies of Hcy concentrations in relation to all AAA, as suggested by asymmetrical funnel plot on visual inspection and Egger's linear regression test (p = 0.049). Third, there was significant heterogeneity (I<sup>2</sup> = 92.9% in all AAA) among the included studies. Another potential source of heterogeneity was the lack of uniform definition of subjects. Forth, a major limitation was the possibility of uncontrolled confounding, and the individual studies did not adjust for potential risk factors in a consistent way. A wide spectrum of diseases was associated with elevated plasma Hcy concentrations, such as cardiovascular disease, stroke and cognitive impairment. These diseases were also associated with AAA; some residual confounding factors still affected the results. None of the analyzed studies seems to have adjusted Hcy levels for its most important covariate, glomerular filtration rate (GFR), and this is a major problem for the outcome. The lack of adjustment for these confounding factors might have resulted in a slight over estimation of the OR. Finally, the studies of Wong YYE and the Brunelli T contained only men, and that may make the findings have only limited relevance to AAA in women <xref ref-type="bibr" rid="pone.0085831-Wong1">[5]</xref>, <xref ref-type="bibr" rid="pone.0085831-Brunelli1">[23]</xref>.</p>
</sec><sec id="s5">
<title>Conclusions</title>
<p>In conclusion, this meta-analysis and systematic review provided evidence that Hcy was associated with AAA. Whether this link is causal remained to be clarified further by future studies. More well-design RCTs on the effect of Hcy-lowering therapy on the prevention or treatment of AAA would be helpful to clarify this question.</p>
</sec><sec id="s6">
<title>Supporting Information</title>
<supplementary-material id="pone.0085831.s001" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0085831.s001" position="float" xlink:type="simple"><label>Checklist S1</label><caption>
<p><bold>PRISMA checklist.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0085831-Cosford1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cosford</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Leng</surname><given-names>GC</given-names></name> (<year>2007</year>) <article-title>Screening for abdominal aortic aneurysm</article-title>. <source>Cochrane Database Syst Rev</source> <volume>2</volume>: <fpage>CD002945</fpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Maegdefessel1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maegdefessel</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Spin</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Adam</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Raaz</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Toh</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Micromanaging abdominal aortic aneurysms</article-title>. <source>Int J Mol Sci</source> <volume>14</volume>: <fpage>14374</fpage>–<lpage>14394</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Go1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Go</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Mozaffarian</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Roger</surname><given-names>VL</given-names></name>, <name name-style="western"><surname>Benjamin</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Berry</surname><given-names>JD</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Executive summary: Heart disease and stroke statistics–2013 update: A report from the american heart association</article-title>. <source>Circulation</source> <volume>127</volume>: <fpage>143</fpage>–<lpage>152</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Harrison1"><label>4</label>
<mixed-citation publication-type="other" xlink:type="simple">Harrison SC, Smith AJ, Jones GT, Swerdlow DI, Rampuri R, <etal>et al</etal>.. (2012) Interleukin-6 receptor pathways in abdominal aortic aneurysm. Eur Heart J. doi: 10.1093/eurheartj/ehs354.</mixed-citation>
</ref>
<ref id="pone.0085831-Wong1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname><given-names>YY</given-names></name>, <name name-style="western"><surname>Golledge</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Flicker</surname><given-names>L</given-names></name>, <name name-style="western"><surname>McCaul</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Hankey</surname><given-names>GJ</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Plasma total homocysteine is associated with abdominal aortic aneurysm and aortic diameter in older men</article-title>. <source>J Vasc Surg</source> <volume>58</volume>: <fpage>364</fpage>–<lpage>370</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Giusti1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Giusti</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Saracini</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bolli</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Magi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sestini</surname><given-names>I</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm</article-title>. <source>J Med Genet</source> <volume>45</volume>: <fpage>721</fpage>–<lpage>730</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Selhub1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Selhub</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jacques</surname><given-names>PF</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>PW</given-names></name>, <name name-style="western"><surname>Rush</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rosenberg</surname><given-names>IH</given-names></name> (<year>1993</year>) <article-title>Vitamin status and intake as primary determinants of homocysteinemia in an elderly population</article-title>. <source>JAMA</source> <volume>270</volume>: <fpage>2693</fpage>–<lpage>2698</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Homocysteineloweringtrialists1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Homocysteine lowering trialists'</surname><given-names>collaboration</given-names></name> (<year>1998</year>) <article-title>Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials</article-title>. <source>BMJ</source> <volume>316</volume>: <fpage>894</fpage>–<lpage>898</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-vanWijngaarden1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Wijngaarden</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Doets</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Szczecinska</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Souverein</surname><given-names>OW</given-names></name>, <name name-style="western"><surname>Duffy</surname><given-names>ME</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Vitamin B12, folate, homocysteine, and bone health in adults and elderly people: A systematic review with meta-analyses</article-title>. <source>J Nutr Metab</source> <volume>2013</volume>: <fpage>486186</fpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Berti1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berti</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fekete</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Dullemeijer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Trovato</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Souverein</surname><given-names>OW</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Folate intake and markers of folate status in women of reproductive age, pregnant and lactating women: A meta-analysis</article-title>. <source>J Nutr Metab</source> <volume>2012</volume>: <fpage>470656</fpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Humphrey1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Humphrey</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Rogers</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Freeman</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Helfand</surname><given-names>M</given-names></name> (<year>2008</year>) <article-title>Homocysteine level and coronary heart disease incidence: A systematic review and meta-analysis</article-title>. <source>Mayo Clin Proc</source> <volume>83</volume>: <fpage>1203</fpage>–<lpage>1212</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-MartiCarvajal1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marti-Carvajal</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Sola</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Lathyris</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Karakitsiou</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Simancas-Racines</surname><given-names>D</given-names></name> (<year>2013</year>) <article-title>Homocysteine-lowering interventions for preventing cardiovascular events</article-title>. <source>Cochrane Database Syst Rev</source> <volume>1</volume>: <fpage>CD006612</fpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Wald1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wald</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Law</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>JK</given-names></name> (<year>2002</year>) <article-title>Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis</article-title>. <source>BMJ</source> <volume>325</volume>: <fpage>1202</fpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Casas1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Casas</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Bautista</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Smeeth</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hingorani</surname><given-names>AD</given-names></name> (<year>2005</year>) <article-title>Homocysteine and stroke: Evidence on a causal link from mendelian randomisation</article-title>. <source>Lancet</source> <volume>365</volume>: <fpage>224</fpage>–<lpage>232</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Yang1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Homocysteine level and risk of fracture: A meta-analysis and systematic review</article-title>. <source>Bone</source> <volume>51</volume>: <fpage>376</fpage>–<lpage>382</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Cahill1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cahill</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Stinnett</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Fekrat</surname><given-names>S</given-names></name> (<year>2003</year>) <article-title>Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease</article-title>. <source>Am J Ophthalmol</source> <volume>136</volume>: <fpage>1136</fpage>–<lpage>1150</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-McGimpsey1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McGimpsey</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Woodside</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Cardwell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cahill</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chakravarthy</surname><given-names>U</given-names></name> (<year>2009</year>) <article-title>Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: A meta-analysis</article-title>. <source>Ophthalmology</source> <volume>116</volume>: <fpage>1778</fpage>–<lpage>1787</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Pianka1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pianka</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Almog</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Man</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Goldstein</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sela</surname><given-names>BA</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion</article-title>. <source>Ophthalmology</source> <volume>107</volume>: <fpage>1588</fpage>–<lpage>1592</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Peeters1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peeters</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>van Landeghem</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Graafsma</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Kranendonk</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Hermus</surname><given-names>AR</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Low vitamin B6, and not plasma homocysteine concentration, as risk factor for abdominal aortic aneurysm: A retrospective case-control study</article-title>. <source>J Vasc Surg</source> <volume>45</volume>: <fpage>701</fpage>–<lpage>705</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Sofi1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sofi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Marcucci</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Giusti</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Pratesi</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lari</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>High levels of homocysteine, lipoprotein (a) and plasminogen activator inhibitor-1 are present in patients with abdominal aortic aneurysm</article-title>. <source>Thromb Haemost</source> <volume>94</volume>: <fpage>1094</fpage>–<lpage>1098</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Warsi1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Warsi</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Davies</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Morris-Stiff</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Hullin</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Lewis</surname><given-names>MH</given-names></name> (<year>2004</year>) <article-title>Abdominal aortic aneurysm and its correlation to plasma homocysteine, and vitamins</article-title>. <source>Eur J Vasc Endovasc Surg</source> <volume>27</volume>: <fpage>75</fpage>–<lpage>79</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Spark1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Spark</surname><given-names>JI</given-names></name>, <name name-style="western"><surname>Laws</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Fitridge</surname><given-names>R</given-names></name> (<year>2003</year>) <article-title>The incidence of hyperhomocysteinaemia in vascular patients</article-title>. <source>Eur J Vasc Endovasc Surg</source> <volume>26</volume>: <fpage>558</fpage>–<lpage>561</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Brunelli1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brunelli</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Prisco</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Fedi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rogolino</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Farsi</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm</article-title>. <source>J Vasc Surg</source> <volume>32</volume>: <fpage>531</fpage>–<lpage>536</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Moroz1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moroz</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Le</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Norman</surname><given-names>PE</given-names></name> (<year>2007</year>) <article-title>Homocysteine and abdominal aortic aneurysms</article-title>. <source>ANZ J Surg</source> <volume>77</volume>: <fpage>329</fpage>–<lpage>332</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Wells1"><label>25</label>
<mixed-citation publication-type="other" xlink:type="simple">Wells GA, Shea B, O′Connell D, Peterson J, Welch V, <etal>et al</etal>.. (2013) The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrand omized studies in meta-analyses. <ext-link ext-link-type="uri" xlink:href="http://www.ohri" xlink:type="simple">http://www.ohri</ext-link>. ca/programs/clinical_epidem iology/oxford.asp. [last accessed 30/3/2013].</mixed-citation>
</ref>
<ref id="pone.0085831-Higgins1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2003</year>) <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source> <volume>327</volume>: <fpage>557</fpage>–<lpage>560</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-DerSimonian1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname><given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Begg1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Egger1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Forsdahl1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Forsdahl</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Solberg</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jacobsen</surname><given-names>BK</given-names></name> (<year>2009</year>) <article-title>Risk factors for abdominal aortic aneurysms: A 7-year prospective study: The tromso study, 1994–2001</article-title>. <source>Circulation</source> <volume>119</volume>: <fpage>2202</fpage>–<lpage>2208</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Krishna1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Krishna</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Dear</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Norman</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Golledge</surname><given-names>J</given-names></name> (<year>2013</year>) <article-title>The potential role of homocysteine mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation</article-title>. <source>Atherosclerosis</source> <volume>228</volume>: <fpage>295</fpage>–<lpage>305</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Feng1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Kong</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Q</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice</article-title>. <source>Cardiovasc Res</source> <volume>84</volume>: <fpage>155</fpage>–<lpage>163</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Liu1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Hyperhomocysteinemia exaggerates adventitial inflammation and angiotensin II-induced abdominal aortic aneurysm in mice</article-title>. <source>Circ Res</source> <volume>111</volume>: <fpage>1261</fpage>–<lpage>1273</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-JourdheuilRahmani1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jourdheuil-Rahmani</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rolland</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Rosset</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Branchereau</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Garcon</surname><given-names>D</given-names></name> (<year>1997</year>) <article-title>Homocysteine induces synthesis of a serine elastase in arterial smooth muscle cells from multi-organ donors</article-title>. <source>Cardiovasc Res</source> <volume>34</volume>: <fpage>597</fpage>–<lpage>602</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Ke1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ke</surname><given-names>XD</given-names></name>, <name name-style="western"><surname>Foucault-Bertaud</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Genovesio</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dignat-George</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lamy</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Homocysteine modulates the proteolytic potential of human arterial smooth muscle cells through a reactive oxygen species dependant mechanism</article-title>. <source>Mol Cell Biochem</source> <volume>335</volume>: <fpage>203</fpage>–<lpage>210</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-denHeijer1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>den Heijer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Graafsma</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>van Landeghem</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Kluijtmans</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Homocysteine levels–before and after methionine loading–in 51 Dutch families</article-title>. <source>Eur J Hum Genet</source> <volume>13</volume>: <fpage>753</fpage>–<lpage>762</lpage>.</mixed-citation>
</ref>
<ref id="pone.0085831-Jee1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jee</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Shim</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HK</given-names></name>, <name name-style="western"><surname>Suh</surname><given-names>I</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Major gene evidence after MTHFR-segregation analysis of serum homocysteine in families of patients undergoing coronary arteriography</article-title>. <source>Hum Genet</source> <volume>111</volume>: <fpage>128</fpage>–<lpage>135</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>